Title | Creator | Description | Identifier | ||
---|---|---|---|---|---|
1 | Baseline OCT Findings in Phase 3 RESCUE and REVERSE Trials | Robert Sergott; Barrett Katz | rAAV2/2-ND4 is an investigational gene therapy facilitating allotopic transgene expression. We report baseline spectral domain OCT of the RNFL and GCL in two Phase 3 trials. | 20180306_nanos_posters_170 |